Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Clinical trial NCT01122927 · TERMINATED

Trial details

NCT number: NCT01122927
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Adolescent Schizophrenia Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features

Start date: 2010-07-01
Primary completion: 2014-08-01
Enrollment: 524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.